Monte Rosa Therapeutics (GLUE) Other Non Operating Income (2023 - 2025)
Historic Other Non Operating Income for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to -$29000.0.
- Monte Rosa Therapeutics' Other Non Operating Income rose 8104.58% to -$29000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 52082.19%. This contributed to the annual value of $416000.0 for FY2024, which is 14473.12% up from last year.
- According to the latest figures from Q3 2025, Monte Rosa Therapeutics' Other Non Operating Income is -$29000.0, which was up 8104.58% from $1.4 million recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Other Non Operating Income registered a high of $1.4 million during Q2 2025, and its lowest value of -$779000.0 during Q4 2023.
- Over the past 3 years, Monte Rosa Therapeutics' median Other Non Operating Income value was -$29000.0 (recorded in 2025), while the average stood at $92727.3.
- Its Other Non Operating Income has fluctuated over the past 5 years, first plummeted by 66666.67% in 2024, then soared by 272264.15% in 2025.
- Monte Rosa Therapeutics' Other Non Operating Income (Quarter) stood at -$779000.0 in 2023, then soared by 100.26% to $2000.0 in 2024, then plummeted by 1550.0% to -$29000.0 in 2025.
- Its Other Non Operating Income stands at -$29000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $173000.0 for Q1 2025.